Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcein, also known as Oftasceine or Fluorexon, is a fluorescent dye belonging to the xanthene family. Its acetoxymethyl ester derivative, Calcein AM, is a non-fluorescent, cell-permeant compound. Upon entering live cells, intracellular esterases hydrolyze Calcein AM, converting it into highly fluorescent Calcein, which is then retained within the cell. This mechanism makes Calcein a valuable tool for assessing cell viability, membrane integrity, and for short-term cell labeling in various biological assays. It is also used as an indicator for lipid vesicle leakage and as an ophthalmic staining agent in procedures like Goldmann applanation tonometry and contact lens fitting. Calcein's fluorescence properties allow for the visualization and quantification of cellular processes and structures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Calcein.